SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%
新闻
FGEN
--
0.00%
--
IPO Update: Pliant Therapeutics Readies U.S. IPO
Seeking Alpha - Article · 3天前
FibroGen to Present at Upcoming Investor Conferences
GlobeNewswire · 4天前
The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on May 20.)
Benzinga · 05/21 12:01
European Medicines Agency Accepts Astellas' Marketing Authorization Application for Roxadustat
PR Newswire · 05/21 03:00
FibroGen, Inc. (NASDAQ:FGEN) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Simply Wall St. · 05/11 11:32
FibroGen Inc (FGEN) Q1 2020 Earnings Call Transcript
Motley Fool · 05/09 22:01
FibroGen, Inc. (FGEN) CEO Enrique Conterno on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/09 20:05
Edited Transcript of FGEN earnings conference call or presentation 7-May-20 9:00pm GMT
Thomson Reuters StreetEvents · 05/08 21:21
SVB Leerink Maintains Outperform on FibroGen, Lowers Price Target to $80
SVB Leerink maintains FibroGen (NASDAQ:FGEN) with a Outperform and lowers the price target from $85 to $80.
Benzinga · 05/08 16:59
FibroGen to Present at Bank of America Securities 2020 Health Care Conference
GlobeNewswire · 05/08 12:00
FibroGen (FGEN) Reports Q1 Loss, Lags Revenue Estimates
Zacks · 05/08 01:40
FibroGen EPS misses by $0.61, misses on revenue
FibroGen (NASDAQ:FGEN): Q1 GAAP EPS of -$0.89 misses by $0.61. Revenue of $24.4M (+2.3% Y/Y) misses by $48.18M. Shares -0.06%. Press Release
seekingalpha · 05/08 01:29
FibroGen Reports First Quarter 2020 Financial Results
GlobeNewswire · 05/07 21:01
FibroGen Q1 EPS $(0.890) Down From $(0.530) YoY, Sales $24.401M Up From $23.863M YoY
FibroGen (NASDAQ:FGEN) reported quarterly losses of $(0.890) per share. This is a 67.92 percent decrease over losses of $(0.530) per share from the same period last year. The company reported $24.401 million in sales
Benzinga · 05/07 20:32
Akebia Shares Climb on Positive Anemia Drug Study Results
GuruFocus.com · 05/07 16:24
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.)
Benzinga · 05/07 11:42
FibroGen Q1 2020 Earnings Preview
FibroGen (NASDAQ:FGEN) is scheduled to announce Q1 earnings results on Thursday, May 7th, after market close. The consensus EPS Estimate is -$0.48 (+9.4% Y
seekingalpha · 05/07 02:35
Why FibroGen (FGEN) Might Surprise This Earnings Season
Zacks · 05/06 13:43
How Does Investing In FibroGen, Inc. (NASDAQ:FGEN) Impact The Volatility Of Your Portfolio?
Simply Wall St. · 05/03 15:17
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck & Co., Inc. (NYSE: MRK) and Pfizer Inc.
Benzinga · 05/03 12:46